Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 334 results found. Search for [ Sun Pharmaceuticals ]

Results 1 to 21 of 334
PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
November 7, 2019
Sun Pharma Q2 result today: The drug major's share price was trading higher ahead of the firm's Q2 earnings


PTI
October 9, 2019



PTI
October 8, 2019



Reuters
New Delhi, September 27, 2019
The move comes after the USFDA asked the company to test the drug for indications of N-nitrosodimethylamine (NDMA) impurity, which the regulator says is a 'probable human carcinogen'


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


BusinessToday.In
September 6, 2019
The share price of Sun Pharma fell 4.01% to Rs 414.60 after the company accepted the allegations of a SEBI ordered forensic audit on company's financial statements.


PTI
September 2, 2019



PTI
August 12, 2019



BusinessToday.In
New Delhi, August 12, 2019
RIL Annual General Meeting: Mukesh Ambani's statement comes days after Prime Minister Narendra Modi called on businesses to invest in J&K and Ladakh


E Kumar Sharma
New Delhi, August 8, 2019
Given the low cost of electricity, favourable weather conditions and water availability, industry players feel that Jammu & Kashmir can be an important manufacturing hub of pharmaceutical companies


BusinessToday.In
August 7, 2019
Reacting on revocation of Article 370, Uday Kotak said that the Jammu and Kashmir has strong potential for development as it enjoys a range of natural resources and immense talent


BusinessToday.In
New Delhi, August 3, 2019
After this move, nearly 80 employees have lost their jobs at Vadodara's R&D unit of Sun Pharma.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PB Jayakumar
New Delhi, July 15, 2019
With over Rs 11,000 crore debt and an impending $172 million FCCB payout next month, Suzlon is negotiating with lenders and potential investors


PTI
June 7, 2019



BusinessToday.In
May 30, 2019
Share Market Updates: Suzlon, Justdial, Infibeam, DCM Shriram and Adani Power were the top gainers on BSE, while on NSE, YES Bank, Bharti Airtel, NTPC, TCS and Bajaj Finance were the top gaining stocks.


BusinessToday.In
May 23, 2019
Share Market Live:Earlier in the day, Sensex gained 1,000 points to breach the historic 40,000 mark for the first time ever. Nifty too crossed the key 12,000 mark and set a new record for the index's new high on the back of early counting in Lok Sabha election indicating PM Narendra Modi was set to storm back to power with a thumping majority.


E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


PTI
May 14, 2019
In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter


PAGES 1 OF 17  12345